Penumbra stock gapped up Wednesday after the medtech company beat fourth-quarter expectations, though its revenue guidance came in shy. Shares of medical device company Penumbra (NYSE:PEN) jumped ...
Penumbra, Inc.’s PEN thrombectomy business is thriving, driven by growing sales of the U.S. vascular thrombectomy and CAVT (computer-assisted vacuum thrombectomy) line of products. The company ...
Expert Rev Cardiovasc Ther. 2009;7(1):29-48. Several additional trials are using identification of a penumbra by neuroimaging for the inclusion of patients. The ReoPro Retavase Reperfusion of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback